MedTrace Logo

The NanoStrand Clinical Study

NCT03871400 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2020-10-19

No results posted yet for this study

Summary

A prospective, multi-center, randomized, self-controlled, single-blinded, clinical study evaluating the NanoMetalene implant as compared to the PEEK and allograft implants in ACDF for the treatment of cervical degenerative disc disease (DDD).

Conditions

  • Disc Degeneration;Cervical

Interventions

PROCEDURE

Anterior cervical discectomy and fusion

primary, 2-level, contiguous

Sponsors & Collaborators

  • SeaSpine, Inc.

    lead INDUSTRY

Principal Investigators

  • Khalid Abbed, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-18
Primary Completion
2020-06-15
Completion
2021-01-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03871400 on ClinicalTrials.gov